UnitedHealth Group (NYSE:UNH) was downgraded by stock analysts at Monness Crespi & Hardt to a “sell” rating in a report issued on Tuesday, AnalystRatings.Net reports. They currently have a $59.00 price objective on the stock. Monness Crespi & Hardt’s price target would indicate a potential downside of 18.64% from the company’s current price. A number […]
UnitedHealth Group Stock Rating Lowered by Monness Crespi & Hardt (UNH) is a post from: Zolmax
The post UnitedHealth Group Stock Rating Lowered by Monness Crespi & Hardt (UNH) appeared first on Zolmax.